# Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth

**Authors:** Zhiqing Liu, Wenhua Huang, Shanhua Xu, Meilan Nan, Xian Cui, Yue Wang, Zhehu Jin, Wan Meng, Jingbi Meng, Longquan Pi

PMC · DOI: 10.3390/ph19010011 · 2025-12-20

## TL;DR

A natural clay mineral called illite can deliver minoxidil for hair growth without causing irritation, and it may even help hair grow on its own.

## Contribution

Illite acts as an effective, non-irritating drug carrier and shows intrinsic hair-growth-promoting activity.

## Key findings

- Modified illite increased surface area and successfully loaded minoxidil.
- Illite-based formulations showed equivalent efficacy to free minoxidil without solvent toxicity.
- Illite increased cell proliferation and reduced apoptosis, suggesting pro-hair growth mechanisms.

## Abstract

Background: Topical minoxidil remains the only FDA-approved treatment for hair loss, yet its clinical efficacy is compromised by organic-solvent-induced scalp irritation and poor patient adherence. This study aimed to evaluate natural illite as a carrier for minoxidil and to explore its potential hair-growth-promoting mechanisms. Methods: Thermal–acid-modified illite was engineered as a spray-dried, hydroalcohol-free minoxidil carrier for topical application. Hair regrowth efficacy was assessed in C57BL/6 mice via a 14-day depilation model. Mechanisms were elucidated via RNA-seq, Ki67/TUNEL immunofluorescence, and p-STAT3 immunohistochemistry. Results: Modified illite resulted in a 4.2-fold surface area increase and successful minoxidil loading. The minoxidil/illite formulation demonstrated efficacy equivalent to that of free minoxidil while also eliminating solvent toxicity. Mechanistic analysis revealed that illite functions as an active carrier: both the illite-alone and minoxidil/illite-treated groups exhibited increased Ki67+ proliferation and reduced TUNEL+ apoptosis. Transcriptomic profiling demonstrated dual mechanisms—enrichment of Myc proliferation pathways and suppression of IL-6 inflammatory signaling (p < 0.001)—with reduced p-STAT3 expression confirmed by immunohistochemistry. Conclusions: These findings suggest that an illite-based carrier can enable topical delivery of minoxidil with preserved efficacy and that illite itself exhibits intrinsic hair-growth-promoting activity via anti-inflammatory and pro-proliferative mechanisms, which may help alleviate adherence barriers associated with conventional topical alopecia therapy.

## Linked entities

- **Proteins:** Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Chemicals:** minoxidil (PubChem CID 4201), illite (PubChem CID 86278147)
- **Diseases:** alopecia (MONDO:0004907)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}
- **Diseases:** toxicity (MESH:D064420), scalp irritation (MESH:D004476), inflammatory (MESH:D007249), alopecia (MESH:D000505)
- **Chemicals:** Thermal (-), minoxidil (MESH:D008914), illite (MESH:C099089)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845174/full.md

---
Source: https://tomesphere.com/paper/PMC12845174